Novel Biologics. Designed by Evolution. Discovered by AI.
AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases.
Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 63 University Road, Belfast,northern Ireland Bt7 1nf,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://amplydiscovery.com/
- Keywords
- Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, Bioinformatics.
- HQ
- Belfast, Northern Ireland
- Competitors
- Lightsonic, JUPUS, akeno, Lamin, Alice.tech, Co-one, AilseBio, DefendEye, Noota, Skillvue.
Amply Discovery Questions
Amply Discovery's website is https://amplydiscovery.com/
Amply Discovery's LinkedIn profile is https://uk.linkedin.com/company/amply-discovery
Amply Discovery has
6 employees.
View email and phone details for 6
employees at Amply Discovery.
Amply Discovery's industry is
Biotechnology Research
Amply Discovery's top competitors are
Lightsonic,
Jupus,
Akeno,
Lamin,
Alice.tech,
Co-One,
Ailsebio,
Defendeye,
Noota,
Skillvue.
Amply Discovery's categories are Biotechnology Research
Amply Discovery's founding year is 2021
